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Specification of primordial germ cells (PGCs) marks
the beginning of the totipotent state. However,
without a tractable experimental model, the mecha-
nism of human PGC (hPGC) specification remains
unclear. Here, we demonstrate specification of
hPGC-like cells (hPGCLCs) from germline compe-
tent pluripotent stem cells. The characteristics of
hPGCLCs are consistent with the embryonic hPGCs
and a germline seminoma that share a CD38 cell-sur-
face marker, which collectively defines likely pro-
gression of the early human germline. Remarkably,
SOX17 is the key regulator of hPGC-like fate,
whereas BLIMP1 represses endodermal and other
somatic genes during specification of hPGCLCs.
Notable mechanistic differences between mouse
and human PGC specification could be attributed
to their divergent embryonic development and
pluripotent states, which might affect other early
cell-fate decisions. We have established a founda-
tion for future studies on resetting of the epigenome
in hPGCLCs and hPGCs for totipotency and the
transmission of genetic and epigenetic information.
INTRODUCTION
Primordial germ cells (PGCs) are the precursors of sperm and
eggs, which generate the totipotent state. The genetic basis of
mammalian PGC specification was first established in mice (Sai-
tou et al., 2002; Ohinata et al., 2005; Hayashi et al., 2007), which
are specified from postimplantation epiblast cells on embryonic
day (E)6.25 in response to bonemorphogenetic protein 4 (BMP4)
(Lawson et al., 1999). Subsequently, 35 founder PGCs are de-
tected at E7.25. Similar studies on human PGCs (hPGCs) would
require E9–E16 embryos, which is not practicable. However, em-
bryonic hPGCs at approximately week 5 to 10 of development,
which correspond to mouse PGCs at E10.5–E13.5, can in princi-
ple be examined (Leitch et al., 2013). These cells retain charac-teristic of PGCs while they undergo resetting of the epigenome
and global DNA demethylation (Hackett et al., 2012).
In mice, BMP4 induces expression of BLIMP1 (encoded by
Prdm1) and PRDM14 in the postimplantation epiblast at E6.25;
together with AP2g (encoded by Tfap2c), a direct target of
BLIMP1, they induce PGC fate (Magnu´sdo´ttir et al., 2013; Nakaki
et al., 2013). The tripartite genetic network acts combinatorially
to repress somatic genes, induce expression of PGC genes,
such as Nanos3, reinduce pluripotency genes, and initiate the
epigenetic program (Hackett et al., 2013; Magnu´sdo´ttir and Sur-
ani, 2014). PGC-like cells (PGCLCs) can also be induced in vitro
from naive pluripotent mouse embryonic stem cells (mESCs)
after they acquire competence for germ cell fate after48 hr cul-
ture in basic fibroblast growth factor (bFGF) and Activin A (Hay-
ashi et al., 2011). These competent cells acquire PGC-like fate in
response to either BMP4 signal or directly to Blimp1, Prdm14,
and Tfap2c, which is similar to PGCs in vivo (Magnu´sdo´ttir
et al., 2013; Nakaki et al., 2013).
Human PGCLCs (hPGCLCs) have been generated at a low fre-
quency by spontaneous differentiation of human ESCs (hESC)
in vitro (Gkountela et al., 2013; Kee et al., 2009), but systematic
studies to characterize and identify the key regulators of hPGCs
remain to be elucidated. Because there are evident differences
between the regulation of mouse and human pluripotent ESCs
(Hackett and Surani, 2014; Nichols and Smith, 2009) and during
their early postimplantation development (de Fellici, 2013; De
Miguel et al., 2010; Irie et al., 2014), this might affect the mech-
anism and the role of the key regulators of hPGCLC specification
(Imamura et al., 2014; Pera, 2013). Once the mechanism of
hPGCLC specification is established, it could provide insights
on the progression of the early human germline with reference
to embryonic hPGCs and seminomas that originate from human
germ cells in vivo and retain key characteristics of the lineage
(Looijenga et al., 2014).
We have developed a robust approach for hPGCLC specifica-
tion from germ cell competent hESCs/hiPSCs (Gafni et al., 2013).
We show that SOX17, a critical transcription factor for endoderm
lineages, is the earliest marker of hPGCLCs and is in fact the key
regulator of hPGCLC fate, which is not the case in mice (Hara
et al., 2009; Kanai-Azuma et al., 2002). BLIMP1 is downstream
of SOX17, and it represses endodermal and other somatic genesCell 160, 253–268, January 15, 2015 ª2015 The Authors 253
during hPGCLC specification. Comparisons among hPGCLCs,
embryonic hPGCs, and a seminoma indicate likely progression
of the early human germline. These cells also exhibit CD38 cell
surface marker, which is shared by cells with germ cell charac-
teristics. We anticipate that genome editing approaches with
our robust in vitro model for hPGCLC specification, combined
with patient-specific human-induced pluripotent stem cells
(hiPSCs), will lead tomajor advances in human germ cell biology,
including on the unique germline-specific epigenetic program
with potential consequences for subsequent generations.
RESULTS
Generation of hPGCLCs from Embryonic Stem Cells
First, we generated three independent hESC lines (WIS2 and
LIS1 male hESC and WIBR3 female hESC line) (Gafni et al.,
2013) with a NANOS3-mCherry knockin reporter (Figure S1A
available online), a highly conserved PGC-specific gene (Gkoun-
tela et al., 2013; Julaton and Reijo Pera, 2011). These
hESCs maintained in bFGF and responded to BMP2/BMP4
with 0%–5% NANOS3-mCherry positive putative hPGCLCs
at day 4 (see Figure 7A). Like hESC, mouse epiblast stem cells
(mEpiSC) also respond poorly to specification of PGCLCs (Hay-
ashi and Surani, 2009). In contrast, epiblast-like cells (EpiLCs)
derived from naive mESCs have a significant potential for germ
cell fate (Hayashi et al., 2011). However, the approach used
for mouse ESCs did not confer competence for germline fate
on hESCs.
Next, we tested hESC-NANOS3-mCherry cells that were
maintained in four-inhibitor-containing medium with LIF, bFGF,
and TGFb (adopted and modified from NHSM conditions; see
Experimental Procedures), henceforth called ‘‘4i’’ medium,
which endows the cells with a distinct pluripotent state (Gafni
et al., 2013). These hESCs were then cultured for 2 days in
bFGF, TGFb, and 1% KSR medium, and thereafter, 2,000–
4,000 cells were cultured in low-attachment well in the presence
of BMP2 or BMP4, LIF, stem cell factor (SCF), epidermal growth
factor (EGF), and Rho-kinase (ROCK) inhibitor to induce
hPGCLCs (Hayashi et al., 2011; Watanabe et al., 2007) (Fig-
ure 1A). These cells aggregated to form embryoid bodies (hence-
forth called embyoids) and responded within 3 days with signif-
icant expression of NANOS3-mCherry and tissue-nonspecific
alkaline phosphatase (TNAP), a PGC and pluripotency marker
in humans and mice (Figure 1B). The intensity of the NANOS3-
mCherry reporter increased progressively until day 4–5, resulting
in 27% of NANOS3/TNAP double-positive putative hPGCLCs
(Figures 1B and S1B). Similar to mice, hPGCLCs do not prolifer-
ate significantly after 5 days under these conditions (Hayashi
et al., 2011). The response was highly reproducible in three inde-
pendent male and female NANOS3-mCherry hESC lines. Both
BMP2 and/or BMP4 (with LIF, SCF, and EGF) were effective in
inducing hPGCLC (Figure S1C) in a dose-dependent manner in
the range of 50–500 ng/ml (Figures S1D and S1E).
The NANOS3/TNAP double-positive putative hPGCLCs also
expressed key PGC genes, including NANOS3, BLIMP1,
TFAP2C, STELLA, TNAP, KIT, OCT4, and NANOG, as well as
PRDM14, albeit with reduced levels compared to hESC (Fig-
ure 1C). Remarkably, SOX17 was significantly upregulated,254 Cell 160, 253–268, January 15, 2015 ª2015 The Authorswhereas SOX2 was downregulated in the putative hPGCLCs
that reflects their expression in embryonic hPGCs and semino-
mas (de Jong et al., 2008; see Figure 2), which is not the
case in mouse PGCs. Immunofluorescence confirmed that
NANOS3-mCherry expression coincided with OCT4, NANOG,
and TFAP2C in day 4 embryoids (Figures 1D and S1F), as did
OCT4 with BLIMP1 (Figure S1F). This suggests that the
NANOS3-mCherry-positive cells are very likely nascent germ
cells.
RNA-Seq Analysis of hPGCLCs: Comparisonwith hPGCs
and Seminoma
We carried out RNA sequencing (RNA-seq) on NANOS3/TNAP
double-positive cells from day 4 embryoids and compared
themwith the gonadal hPGCs fromweek 7male human embryos
(Carnegie stage 18/19), which are equivalent to mouse E12.5–
E13.5 PGCs (Leitch et al., 2013). These hPGCs retain key
characteristics of earlier hPGCs but, consistent with their more
advanced state, expresses later germ cell markers such as
VASA and DAZL. We also included TCam-2, a human seminoma
that originates from the germline in vivo (Looijenga et al., 2014).
Unsupervised hierarchical clustering of global gene expres-
sion showed that the hPGCLCs clustered with hPGCs and
TCam-2, whereas 4i hESCs and preinduced cells (4i hESCs
treated with bFGF and TGFb for 2 days) clustered together in
another branch away from gonadal somatic cells (soma) (Fig-
ure 2A). Consistently, hPGCs were globally more related
to hPGCLCs (Pearson correlation coefficient [r] = 0.85) and
TCam-2 (r = 0.818) than to 4i hESCs (r = 0.799) and preinduced
cells (r = 0.773) (Figure S2A).
A heat map of mRNA expression revealed that hPGCLCs
and gonadal hPGCs shared expression of early PGCs (BLIMP1,
TFAP2C, DND1, NANOS3, UTF1, ITGB3, and KIT) and pluripo-
tency genes (TNAP, OCT4, NANOG, PRDM14, and LIN28A)
but with a notable lack of SOX2 expression (Figure 2C). Early
mesoderm marker T was detected in hPGCLCs (Figure 2C), as
inmouse early PGCs (Aramaki et al., 2013). Interestingly, expres-
sion of two endodermal genes, SOX17 and GATA4, was de-
tected in hPGCLCs, embryonic hPGCs, and TCam-2, which
are absent in the mouse germline. Notably, we identified CD38
expression in hPGCLCs/hPGCs and TCam-2, but not in hESCs
or soma (Figures 2C and see also Figures 3A–3C). Overall,
hPGCLCs indeed have germ cell characteristics consistent
with hPGCs. Late germ cell markers, however, including DAZL,
VASA, and MAEL, were only detected in hPGCs (Figure 2C).
TCam-2 gene expression was similar to hPGCLCs, albeit with
lower expression levels ofNANOS3, ITGB3, and T and upregula-
tion of a few somatic genes, e.g., HAND1 and RUNX1. Immuno-
fluorescence analysis validated the expression of BLIMP1,
TFAP2C, and OCT4 in hPGCLCs/hPGCs and TCam-2 (Figures
2E–2H). Interestingly, PRDM14 showed nuclear localization in
the majority of hPGCLCs but was predominantly enriched in
the cytoplasm of hPGCs (Figure 2F). Importantly, although
SOX2 was undetectable, there was significant expression of
SOX17 in hPGCLCs, hPGCs, and TCam-2 (Figures 2G and 2H).
Given the similarities of hPGCLCs, hPGCs, and TCam-2,
a three-way Venn diagram was plotted to investigate their rela-
tionships (Figure 2D). Out of 972 highly upregulated genes
Figure 1. Specification of hPGCLCs from Human Embryonic Stem Cells
(A) Schematic protocol for hPGCLCs specification from hESCs.
(B) Development of day 1–7 embryoids derived from WIS2-NANOS3-mCherry hESCs. Top row: images of embryoids. Bottom row: FACS analysis of the
dissociated embryoids with anti-TNAP-Alexa Fluor 647 and NANOS3-mCherry to detect hPGCLCs.
(C) Expression analysis by RT-qPCR of TNAP-positive 4i hESCs (hESC TNAP+), TNAP/NANOS3-mCherry-positive hPGCLCs (TNAP+N3+), and the remaining
cells (TNAP-N3-) of day 4 embryoids (D4 embryoid). Relative expression levels are shown with normalization to bACTIN. Error bars indicate mean ± SD from
three independent biological replicates.
(D) Immunofluorescence of a day 4 embryoid showing coexpression of NANOS3-mCherry, NANOG, and OCT4 in hPGCLCs. Scale bar, 66 mm.
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Figure 2. hPGCLC Shares Transcriptional Profile with Human Embryonic PGCs and TCam-2 Seminoma
(A) Unsupervised hierarchical clustering (UHC) of gene expression in 4i hESC, preinduced cells (Pre-induced), day 4 hPGCLCs (hPGCLC), gonadal hPGC,
TCam-2, and gonadal somatic cell (Soma). RNA-seq was performed on two biological replicates (#1 and #2) for each cell type.
(B) PCA of RNA-seq data. Arrowline indicates potential germline progression from 4i hESC to hPGCLC and gonadal hPGC.
(legend continued on next page)
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compared to soma (Table S1), the three germline-related cell
types shared expression of 161 genes, including pluripotency
and germline-specific genes: BLIMP1, TFAP2C, CD38, SOX17,
OCT4, and NANOG (Figure 2D). Gene ontology (GO biological
process) analysis revealed (Table S1) that hPGCLCs from male
cell line and male gonadal hPGCs were commonly enriched
in ‘‘spermatogenesis’’ genes—for example, NANOS3 and
HIST1H1T—whereas meiosis-related SYCP3, MAEL, and
PIWIL1 genes were upregulated only in embryonic hPGCs (Fig-
ures 2C and 2D). Interestingly, TCam-2 and hPGCs revealed
expression of a number of late germ cell markers, including
Tudor-domain-containing TDRD5, TDRD9, and TDRD12 genes,
which have been implicated in PIWI-interacting RNA biogenesis
pathway (Shoji et al., 2009) (Figure 2D). As expected, TCam-2
showed characteristics associated with cancer cells, including
genes that promote cell proliferation with suppression of
apoptosis genes (Figure 2D). Altogether, hPGCLCs, TCam-2,
and hPGCs share key germ cell characteristics and expressed
the core germ cell genes, including CD38, whereas the differen-
tially expressed genes reflected their corresponding stages of
development and cell identity.
Principal component analysis (PCA) further illustrates the rela-
tionships between the different cell types. PCA reduces dimen-
sionality of whole-genome expression data by transforming
into principal components (PCs), in which the variance within
the dataset is maximal. A three-dimensional (3D) PCA plot of
the first three PCs showed that the 4i hESC, soma, and hPGC-
related cells (hPGCLCs, gonadal hPGCs, and TCam-2) settled
at three discrete positions (Figure 2B). In particular, hPGCLCs,
TCam-2, and gonadal hPGCs aligned together at the lower
extreme of PC2, whereas 4i hESCs and preinduced cells formed
a distinct cluster withmediumPC2 scores and soma at the upper
extreme (Figures 2B and S2B). The relative contributions
(weights) of key germ cell, pluripotency, and gonadal somatic
genes to PC2 and PC3 were plotted as two-dimensional (2D)
loading plot alongside a corresponding 2DPCAplot (Figure S2B).
Indeed, the weights of germ cell, pluripotency, and somatic
genes highly overlap with the position of germ-cell-related cell
types, hESCs, and soma, respectively. Germ-cell-related genes,
such as SOX17, CD38, and NANOS3 loaded heavily for lower
extreme of PC2, where hPGCLCs, TCam-2, and gonadal hPGCs
were aligned. There was a clear difference in weights of early
germ cell genes (commonly expressed in hPGCLCs, TCam-2,
and gonadal hPGCs—for example, BLIMP1 and TFAP2C) and
late germ cell genes (expressed only in gonadal hPGCs or
TCam-2—for example, VASA and DAZL) on PC3, with the latter
weighing more heavily toward low PC3 scores (Figure S2B).
Notably, decreasing scores of PC3 reflected potential progres-
sion of germ cell development from hPGCLCs toward gonadal(C) Heat map of gene expression of key PGC-associated genes (early and late) and
(D) Venn diagram illustrates common and differentially expressed genes. Significa
change) > 3 and adjusted p value < 0.05 versus gonadal Soma, respectively) we
indicated. Text boxes indicate gene ontology biological processes (BP) terms tha
categories absent from BP annotation.
(E–H) Immunofluorescence analysis for (E) BLIMP1, (F) PRDM14, (G) SOX2, and (H
week 7 male gonad (third row), and TCam-2 (bottom row). Samples were counter
embryonic gonad. Arrows indicate cytoplasmic enrichment of PRDM14 (F). ScalhPGCs, whereas TCam-2 aligned between hPGCLCs and
gonadal hPGCs (Figures 2B and S2B).
Taken together, hPGCLCs demonstrate germ cell characteris-
tics that are apparently en route to hPGCs, whereas our objec-
tive analysis placed TCam-2 in an intermediate position, which
reflects their origin from hPGCs in vivo. Notably, hPGCLCs
evidently represent the earliest stages of the human germ cell
lineage, indicating that our in vitro model provides an important
opportunity to explore the mechanism of hPGC specification,
which is otherwise not possible because E9–E14 postimplanta-
tion human embryos are excluded from investigations. TCam-2
and other seminomas might, however, also serve as important
in vitro models of human germ cell biology (Looijenga et al.,
2014; Schafer et al., 2011).
CD38: ACoreMarker of HumanGerm-Cell-Related Cells
and Initiation of the Epigenetic Program
CD38, an established cell-surface glycoprotein on leukocytes, is
a prognostic marker of leukemia (Malavasi et al., 2008). Surpris-
ingly, we detected CD38 expression in hPGCLCs, gonadal
hPGCs, and TCam-2, but not in hESCs or gonadal somatic cells
(Figure 2C). Indeed, fluorescence-activated cell sorting (FACS)
analysis showed that CD38 is present on all the TNAP-positive
embryonic hPGCs and on TCam-2with some heterogeneity (Fig-
ures 3B and 3C). Although CD38 is absent on hESCs, 50% of
the NANOS3-mCherry-positive hPGCLCs were CD38 positive
on day 4 (Figure 3A), which increased to 70% by day 5 (Fig-
ure 3A). Interestingly, the NANOS3-mCherry/CD38 cells had
higher expression of NANOS3, BLIMP1, SOX17, OCT4, and
NANOG (Figure 3D). By contrast, hESCs and embryonic carci-
noma cells exhibit CD30 (also known as TNFRSF8) and SOX2
(Figures 3D and 2G) (Pallesen and Hamilton-Dutoit, 1988).
Thus, CD38 and CD30 could potentially be used as additional
markers of germ cell tumors in vivo (Figure 7D).
The RNA-seq of hPGCLC also revealed gene expression
changes that indicate initiation of the epigenetic program with
downregulation of UHRF1, DNMT3A, and DNMT3B and upregu-
lation of TET1 and TET2 (Figure S3D). Notably, we found a
significant increase in 5-hydroxymethylacytosine (5hmC) in
hPGCLCs, which is consistent with an increase in the expression
of TET1, an enzyme that converts 5-methylcytosine (5mC) to
5hmC (Figures 3E–3G), together with a small but significant
decline in 5mC (Figures 3G and S3A). This indicates that, as in
themouse PGCs, loss of 5mCmight be coupled with the conver-
sion of 5mC to 5hmC (Hackett et al., 2013). At the same time, we
detected a decline in the expression of de novo DNA methyl-
transferase 3A (DNMT3A) and UHRF1 in hPGCLCs compared
to the neighboring somatic cells in the embryoids (Figures 3G,
S3B, and S3C). UHRF1 targets DNMT1 to replication foci toof pluripotency, mesoderm, endoderm, and gonadal somatic (Soma)markers.
ntly upregulated genes in hPGCLC, gonadal hPGC, and TCam-2 (with log2 (fold
re compared. Representative genes that were exclusive to each category are
t were significantly enriched as indicated by p values. Asterisk denotes custom
) SOX17 on 4i hESCs (top row), day 4 hPGCLC embryoids (second row), human
stained with TFAP2C or OCT4 to identify hPGCLCs in embryoids and hPGCs in
e bars, 70 mm.
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Figure 3. CD38 Expression in Human Germ-Cell-Related Cells and Epigenetic Changes in hPGCLCs
(A) FACS analysis of NANOS3-mCherry and CD38 on WIS2-NANOS3-mCherry cell line cultured in 4i medium and on day 4 and 5 embryoids following hPGCLC
induction. Ratios of CD38 low and high expression in the NANOS3-mCherry-positive cells are indicated.
(B) FACS histogram of CD38 low and high populations in TCam-2.
(C) FACS analysis of CD38 and TNAP on genital ridges isolated from a week 6 human embryo.
(D) Expression analysis by RT-qPCR for FACS-sorted TNAP-positive 4i hESCs (TNAP+ hESC) and CD38 low or high/NANOS3-mCherry day 5 hPGCLCs. Relative
expression levels are shown with normalization to bACTIN. Error bars indicate mean ± SD from two independent biological replicates.
(E and F) Immunofluorescence analysis for 5hmC (E) and TET1 (F) on day 4 embryoids cryosection. OCT4 or BLIMP1were used to identify hPGCLCs (highlighted).
Scale bars, 50 mm.
(G) Quantification of immunofluorescence intensity of various epigenetic marks/modifiers in hPGCLCs and somatic neighbors in day 1–4 embryoids (see also
Figures S3A–S3C). For UHRF1, only KI-67-positive (proliferating) cells were used for quantification. Numbers below each box denotes number of cells analyzed.
Black central line represents themedian, boxes andwhiskers represent the 25th and 75th, and 2.5th and 97.5th percentiles, respectively.Wilcoxon signed-rank test
was used to test for statistical significance. #p < 0.05; *p < 0.0001.confer maintenance of DNA methylation (Liu et al., 2013). The
repression of UHRF1 in proliferating (KI-67-positive) hPGCLCs
would allowDNA-replication-coupled loss of 5mC,which is anal-
ogous to the observations on the early mouse germline.
Taken together, day 4 hPGCLCs, which are the nascent hu-
man germ cells, already showed evidence for the initiation of
epigenetic changes and DNA demethylation that are compara-
ble to E8 mouse PGCs (Hackett et al., 2013). Notably, we also
found that PRMT5, an arginine methylatransferase that was
ubiquitously but weakly present in the cytoplasm of day 1 and
2 embryoids, showed enhanced expression in the nucleus of258 Cell 160, 253–268, January 15, 2015 ª2015 The Authorsday 4–8 hPGCLCs (Figure S3E). This is a shared characteristic
with E8 mouse PGCs, hPGCs, and TCam-2 seminoma (Eckert
et al., 2008). The translocation of PRMT5 to the nucleus is impor-
tant for the suppression of transposable elements at the onset of
DNA demethylation (Kim et al., 2014).
Sequential Gene Expression during hPGCLC
Specification in Embryoids
Having established similarities between hPGCLCs and the
authentic hPGCs, we set out to investigate the mechanism
of hPGCLC specification. First, for establishing the precise
Figure 4. Sequential Expression of Germ-
Cell-Related Transcription Factors in Sin-
gle Cells during hPGCLC Specification
(A and B) Immunofluorscence analysis for (A)
BLIMP1, SOX17, and TFAP2C and (B) BLIMP1
and T in cryosections of day 1–8 embryoids after
hPGCLC induction. Bottom row in (B) shows high
exposure (digital) image of T, indicating low but
specific expression in hPGCLC. SOX17-positive
or BLIMP1-positive cells are highlighted. Scale
bars, 50 mm.
(C) Percentage of SOX17-positive (+) cells in day
1–8 embryoids that were also TFAP2C+ or
BLIMP1+. Corresponds to data in Figure 4A.
(D) Percentage of BLIMP1-positive (+) cells in day
1–8 embryoids that were TFAP2C+, NANOG+, or
OCT4+. Corresponds to data in Figures 4A, S4A,
and S4B.
(E) Summary model for dynamics of hPGCLC
specification in embryoids. SOX17-positive cells
are first scattered in day 1 embryoids. They gain
expression of BLIMP1, TFAP2C, and NANOG
sequentially and form a cluster from day 2 onward
until the formation of nascent hPGCLC.sequence of expression of the key hPGC-related genes at the
resolution of single cells, we performed systematic time course
analysis by immunofluorescence on day 1–8 embryoids after
hPGCLC differentiation.
On day 1, we first detected SOX17 in a few widely scattered
cells throughout the embryoids (Figures 4A and 4E). Among
the SOX17-positive (+) cells, 55% were also BLIMP1+, and
22%were TFAP2C+ (Figures 4A and 4C). However, all BLIMP1+
cells coexpressed SOX17, suggesting that SOX17 is upregu-
lated before BLIMP1. The proportion of BLIMP1+ and TFAP2C+
cells increased to 70% on day 2 and to 90% on days 4–8
(Figures 4A and 4C). These triple-positive cells likely represent
specified hPGCLCs, as they also coexpressed other key hPGC
genes. However,10% of single SOX17+ cells failed to undergo
hPGCLC specification but persisted in day 4–8 embryoids.
These may be aberrant cells or else may belong to other
lineages.Cell 160, 253–268,Expression of T is of particular interest,
as it signifies competence for germ cell
fate in mice, and BMPs can induce it in
hESCs (Bernardo et al., 2011; Yu et al.,
2011). Notably, expression of T was high
in the majority of cells on day 1, except
formost of the BLIMP1+ cells (Figure 4B).
By day 2, however, T was dramatically
downregulated in most cells, although
now the BLIMP1+ nascent hPGCLC re-
tained low T expression, which persisted
until at least day 4 (Figure 4B), consistent
with the T transcripts detected by RNA-
seq (Figure 2C). It is possible that BMP
signaling may initially enhance expres-
sion of T in the embryoids (Bernardo
et al., 2011), and it is from this populationthat hPGCLCs are specified, which reflects the events during
mouse PGC induction (Aramaki et al., 2013).
Expression of OCT4 was low but widespread in the day 1 em-
bryoids, including 75% of the BLIMP1+ cells (Figures S4B and
4D). Although the overall OCT4 expression declined dramatically
in day 2 embryoids, it was strongly expressed in 86% of the
BLIMP1+ cells. Subsequently, all BLIMP1+ cells became highly
OCT4+ by day 4. By contrast, NANOG was expressed in
35% of BLIMP1+ cells on day 1, but it was generally absent
in other cells in the embryoids (Figures 4D and S4A). Thereafter,
NANOGwas also rapidly upregulated in the majority of BLIMP1+
cells by day 2–4. The upregulation of key pluripotency genes,
such as OCT4 and NANOG, is also reminiscent of their re-
expression in mouse PGCs (Magnu´sdo´ttir et al., 2013). Although
NANOS3-mCherry expression was weakly detected in 24% of
OCT4+ cells at day 2 (Figure S4C), it was detected in all
OCT4+ cells on day 4, confirming their PGCLC identity.January 15, 2015 ª2015 The Authors 259
(legend on next page)
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PRDM14 is a key regulator of pluripotency in mouse and hu-
man ESCs (Chia et al., 2010; Grabole et al., 2013; Ma et al.,
2011; Yamaji et al., 2013) and is a key regulator of mouse PGC
specification (Yamaji et al., 2008). PRDM14 was generally down-
regulated in day 1–2 embryoids but was detectable in the
nucleus of most BLIMP1+ cells by day 4 (Figure S4A). Notably,
in a minority of BLIMP1/NANOG-positive hPGCLCs at day 8,
PRDM14 was enriched in the cytoplasm (Figure S4A), which
was the case in most of the gonadal hPGCs (Figure 2F). This is
inmarked contrast to the persistent nuclear PRDM14 expression
in mouse PGCs (Grabole et al., 2013).
The SOX17/BLIMP1 double-positive cells were initially distrib-
uted randomly in day 1 embryoids (Figure 4A) but were then
loosely organized in clusters andoften a single cluster in day 2 em-
bryoids. By day 4, generally one and occasionally two tight clus-
ters of hPGCLCs were observed either at the core or periphery
of each embryoid (Figure 4E). Cumulative observations suggest
that SOX17/BLIMP1 might be among the key regulators of
hPGCLC specification. Although OCT4 and NANOG were de-
tected between days 1 and 2 in conjunction with NANOS3-
mCherry and other PGC-specific genes from days 2–4, PRDM14
was upregulated more gradually in hPGCLCs and was subse-
quently detected in thecytoplasmof embryonic hPGCs. Following
the early expression of SOX17 and BLIMP1 in hPGCLCs, these
two transcription factors were also detected in embryonic hPGCs
in vivo, as well as in TCam-2 (Figures 2E and 2H). These observa-
tions suggest that SOX17-BLIMP1 might be among the critical
determinant of hPGC specification and maintenance.
Role of BLIMP1 during hPGCLC Specification
BLIMP1 is the first and key regulator of mouse PGC, and loss of
function abrogates PGC fate (Ohinata et al., 2005; Vincent et al.,
2005). However, BLIMP1 expression is apparently downstream
of SOX17 in hPGCLCs (Figures 4A and 4C). We examined
its mechanistic role by generating BLIMP1 knockout (KO)
NANOS3-mCherry hESC line (Figure S5A). These cells showed
loss of BLIMP1 by western blot (Figure 5A) and immunofluores-
cence (Figure S5B) on day 4 of hPGCLCs induction. Notably,
there was also a loss of NANOS3-mCherry-positive cells,
together with a significant reduction of NANOG, OCT4, and
TFAP2C expression on day 4 (Figures 5C and S5B), indicating
a failure of hPGCLC specification, and all of these cells disap-
peared by day 8 (Figure 5C). However, we detected 8% of
TNAP-positive cells in day 4 embryoids (Figure 5B). This obser-
vation is highly reminiscent of the effects of Blimp1 mutation on
mouse PGC specification (Ohinata et al., 2005).
We isolated and characterized the TNAP-positive cells by
FACS and confirmed loss of BLIMP1, except for low expressionFigure 5. Role of BLIMP1 in hPGCLC Specification
(A) Western blot analysis of BLIMP1 and SOX17 in TNAP-positive (TNAP+) cells so
after hPGCLC induction. TUBULIN was used as loading control.
(B) FACS analysis of TNAP and NANOS3-mCherry on WT and BLIMP1 knockou
(C) Immunofluorscence for OCT4 and SOX17 in cryosections of WT and BLIMP
50 mm.
(D) Expression analysis by RT-qPCR forWT TNAP/NANOS3-mCherry double-pos
KO; TNAP+) sorted from day 4 embryoids. Relative expression levels are show
independent biological replicates.of mutant transcripts (Figure 5D). These cells also showed loss of
NANOS3, UTF1, and KLF4 and reduced expression of TFAP2C,
DND1, OCT4, NANOG, and T (Figures 5D and S5B). In addition,
they showed prominent upregulation of mesodermal/primitive
streak and HOX genes, as well as endodermal genes, including
GATA4, GATA6, FOXA1 HNF1b, and HNF4a (Figure 5D). By
contrast, endodermal genes were not upregulated in Blimp1
mutant mouse PGCs (Kurimoto et al., 2008; Vincent et al.,
2005). This suggests that BLIMP1 probably suppresses
endoderm and other somatic genes, which might otherwise
be induced by SOX17 and BMP signaling during hPGCLCs
specification (Figure 6H). Loss of BLIMP1 and TFAP2C also
caused upregulation of HOX genes in TCam-2 (Weber et al.,
2010). This suggests that one of the roles of BLIMP1 is to
continually suppress the somatic program during human germ-
line development.
SOX17 Is the Key Regulator of hPGCLCs, which Acts
Upstream of BLIMP1
Expression of SOX17 among T-positive cells prior to BLIMP1
apparently marks the onset of hPGCLC specification, which is
a key difference between the specification of human and mouse
germline fate (see Figure 4). Notably, SOX17 and BLIMP1 are
also expressed in the authentic in vivo hPGCs and in TCam-2
(de Jong et al., 2008) (Figure 2). Knockdown of SOX17 in
TCam-2, which exhibits key germ cell characteristics (Looijenga
et al., 2014) (Figure 2), induced repression of the pluripotency
genes NANOG, as well as of the PGC-genes BLIMP1, NANOS3,
TFAP2C, STELLA, and KIT (Figure S6A). This suggests that
SOX17 might be important for regulating the established germ-
line gene expression network.
We addressed the role of SOX17 during hPGCLC specification
by generating SOX17 KO NANOS3-mCherry hESC line (Fig-
ure S6B) and validated absence of SOX17 expression in day 4
embryoids from mutant cells by western blot and immunofluo-
rescence (Figures 6A and S6C). Notably, we did not detect any
NANOS3-mCherry or TNAP-positive cells in the embryoids
from SOX17 mutant cells (Figure 6B). Further, RT-qPCR analysis
of day 4 SOX17 null embryoids showed absence of NANOS3,
TFAP2C, DND1, UTF1, KLF4, OCT4, NANOG, and, importantly,
BLIMP1 (Figure 6C). Instead, there was upregulation of meso-
dermal genes PDGFRA, KDR, and HOXA1 (Figure 6C). Although
a few TFAP2C-positive cells were detected on day 4, they were
BLIMP1 negative and most likely belong to other lineages
(Figure S6C).
To determine whether SOX17 acts cell autonomously, we
mixed wild-type NANOS3-mCherry hESCs with the SOX17 null
hESCs in 1:1 ratio during induction of hPGCLCs by cytokines.rted from wild-type (WT) and BLIMP1 knockout (BLIMP1 KO) day 4 embryoids
t (BLIMP1 KO) day 4 embryoids.
1 KO day 4 and 8 embryoids. OCT4-positive cells are highlighted. Scale bar,
itive cells (WT; TNAP+N3+) andBLIMP1 KOTNAP single-positive cells (BLIMP1
n with normalization to bACTIN. Error bars indicate mean ± SD from two
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All NANOS3-mCherry positive cells detected by immunofluores-
cence on day 4 were SOX17 positive (Figure 6D), indicating that
SOX17 null hESCs did not undergo hPGCLC specification even
in the presence of wild-type cells. The overall number of
NANOS3-mCherry-positive cells in the embryoid with mixed
cells was about half of that in the control consisting of wild-
type cells only (Figure S6D), suggesting that SOX17 null cells
did not affect PGCLC induction from wild-type cells. Thus,
SOX17 null cells have intrinsic defect for hPGCLC specification.
To determine the competency of the SOX17 null hESCs, we
transfected an inducible SOX17 fusion construct with human
glucocorticoid receptor ligand-binding domain (GR) into the
SOX17 null hESCs. This would allow dexamethasone (Dex) to
activate the SOX17-GR and induce translocation of SOX17
fusion protein from the cytoplasm into the nucleus (Brocard
et al., 1998). After 5 days of induction with cytokines and Dex
in the SOX17 null SOX17-GR hESCs, expression of germ cell
genes BLIMP1, TFAP2C, OCT4, NANOG, and KIT and the
TNAP/CD38-positive population was restored (Figures 6E and
6G). This demonstrates that SOX17 null hESCsmaintain compe-
tency for hPGCLC specification. Strikingly, activation of SOX17
alone in the absence of cytokines was sufficient to induce
germ cell genes and TNAP/CD38-positive cells from 4i hESCs
(Figures 6F and 6G). Taken together, SOX17 is indispensable
and sufficient for hPGCLC gene induction from competent
hESCs, and it acts upstream of BLIMP1 and other genes to
initiate the human germ cell transcriptional network (Figure 6H).
Interestingly, loss of SOX17 in TCam-2 also causes a repression
of germ-cell- and pluripotency-associated genes (Figure S6A).
This suggests that SOX17 might also be important for the main-
tenance of the germ cell state because it is also highly expressed
in embryonic hPGCs.
Specification of hPGCLCs from Germ-Cell-Competent
hESC/hiPSCs
Because gene expression of hESCs in 4i medium resembles
that of hESC after preinduction for 2 days in bFGF/TGFb (Fig-
ures 2A, 2B, and S2A), we decided to investigate hPGCLC in-
duction directly in hESCs maintained in 4i medium (Figure 1A).
Indeed, hPGCLCs could be induced directly from 4i hESCsFigure 6. Role of SOX17 in hPGCLC Specification
(A) Western blot analysis of SOX17 expression of WT day 4 TNAP/NANOS3-mC
embryoids. TUBULIN was used as loading control.
(B) FACS analysis of TNAP and NANOS3-mCherry on WT and SOX17 KO day 4
(C) RT-qPCR analysis of TNAP/NANOS3-mCherry FACS-sortedWT double-negat
whole SOX17 KO embryoids (SOX17 KO). Relative expression levels are show
independent biological replicates.
(D) Immunofluorescence of day 4 embryoids derived fromWT, SOX17 knockout (S
of NANOS3-mCherry+ cells with or without SOX17 expression is shown. Quant
embryoids of each condition. Scale bars, 50 mm.
(E and F) FACS analysis of TNAP and CD38 on day 5 embryoids derived from
glucocorticoid receptor ligand-binding domain (SOX17 KO+ SOX17 GR). Embryo
without (Dex) addition of dexamethasone.
(G) RT-qPCR analysis of day 5 hPGCLC derived from WT and SOX17 KO (S17KO
dexamethasone (Dex) and in the presence (+) or absence () of cytokines. FAC
(for S17KO) were used. Relative expression levels are shown with normalization
(H) Model for establishment of hPGC transcription network by SOX17 and BLIMP1
of BLIMP1, downstream of SOX17, suppresses endodermal genes, as well as me
from competent cells upon induction by BMP signaling. The hPGC specificationwith apparent enhanced response resulting in 46% hPGCLCs
(Figure 7A). These hPGCLCs showed a slightly higher intensity
of NANOS3/TNAP by FACS, and a greater proportion of
them were CD38 positive (Figure 7A). Notably, cells maintained
for more than 2 weeks in the conventional hESC medium,
regardless of whether they were initially maintained in 4i
medium, showed a significantly lower numbers of hPGCLCs
(5%) with a reduced intensity of NANOS3-mCherry/TNAP
and CD38 expression (Figure 7A). This demonstrates that
hESCs in 4i medium are highly competent for the hPGCLC
fate. Importantly, the competent state is conferred reversibly
because it is gained and lost in 4i and conventional culture con-
ditions, respectively.
Global gene expression analysis indicated overall similarities
between hESCs in the conventional medium versus those in
‘‘4i’’ medium (r = 0.923) but with notable differences (Figure S7A).
Although these cells showed similar expression levels of core
pluripotency factors OCT4, NANOG, and SOX2, 4i hESCs
had higher expression of mesoderm and gastrulation genes,
including T, RUNX1, and PDGFRA (Figures S7B and S7C and
Table S2). Furthermore, OCT4-positive cells in 4i hESCs had
varying levels of T protein, possibly due to inhibition of GSK3b
(Chen et al., 2013), which is not the case in hESC cultured in con-
ventional condition (Figure S7D). These differences might be
relevant for the mechanism of competence of ESCs for PGCLC,
which merits further investigation.
We also asked whether hiPSCs could be used to generate and
isolate hPGCLCs using the combination of surface markers
CD38 with TNAP (Figures 2C and 3A–3D). Using FX71.1 hiPSCs
(see Experimental Procedures) maintained in 4i medium for
>2 weeks that lack CD38 expression, we detected31% of
TNAP/CD38 double-positive cells after 4 days in response to
cytokines (Figure 7B). TNAP/CD38 double-positive hPGCLCs
showed expression of NANOS3, BLIMP1, TFAP2C, SOX17,
STELLA, T, OCT4, NANOG, and PRDM14, but not of SOX2 (Fig-
ure 7C). Similar results were obtained with another hiPSC line
(C1, Gafni et al., 2013). Thus, hPGCLC specification could be
induced efficiently and directly in hiPSCs that are maintained in
the 4i medium, which could be used for disease modeling using
patient-derived iPSCs.herry-positive hPGCLCs (WT, TNAP+N3+), and whole SOX17 knockout day 4
embryoids.
ive (TNAP-N3-) or -positive (TNAP+N3+) cells sorted from day 4 embryoids and
n with normalization to bACTIN. Error bars indicate mean ± SD from two
OX17 KO), and from 1 to 1mixture ofWT and SOX17 KO 4i hESCs. The number
ification was based on seven to nine confocal images from four independent
SOX17 knockout 4i hESCs containing SOX17 fusion construct with human
ids were derived in the presence (E) or absence (F) of cytokines with (Dex+) or
) and SOX17 KO + SOX17-GR (S17KO+S17GR) hESCs with (+) or without ()
S-sorted NANOS3-mCherry/TNAP double-positive cells or whole embryoids
to GAPDH. Error bars indicate mean ± SD from two biological replicates.
. SOX17 induces germ cell genes and, potentially, endoderm gene. Expression
sodermal genes. As a result, the SOX17-BLIMP1 axis initiates hPGC program
gene network is abrogated in the absence of SOX17 or BLIMP1.
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DISCUSSION
Specification of hPGCLCs from germ cell competent hESC/
hiPSC provides a unique mechanistic view of the establishment
of the human germline (Figure 7D). Notably, SOX17 is the key
regulator of hPGCLC specification, whereas BLIMP1 represses
endodermal and other somatic genes during hPGCLC specifica-
tion. This was unexpected because the primary role of SOX17 is
in the endoderm (D’Amour et al., 2005; Kanai-Azuma et al., 2002)
and because Sox17 has no detectable role in the specification of
mouse PGCs (Hara et al., 2009; Kanai-Azuma et al., 2002). A
comparison among hPGCLCs, embryonic hPGCs, and TCam-
2 seminoma (Looijenga et al., 2014; Schafer et al., 2011) also es-
tablishes the likely progression of the early human germline
(Figure 2B).
During hPGCLC specification from hESCs, SOX17 was first
detected in a few scattered cells in day 1 embryoids, which
showed expression of T. The nascent hPGCLCs subsequently
form a few or a single cluster in day 4–8 embryoids. SOX17 is
indeed essential for hPGCLC specification, and this gene alone
is sufficient to induce germ cell genes in the SOX17mutant cells,
with or without cytokines from 4i hESCs. SOX17 acts cell auton-
omously, and the presence of mutant cells in embryoids had no
effect on hPGCLC specification from wild-type cells. It will be of
interest to see how SOX17, with or without BLIMP1, determines
cell fates between germ cell, hematopoietic, and endodermal
lineages (Nakajima-Takagi et al., 2013; Clarke et al., 2013).
Expression of BLIMP1 is intimately associated with SOX17
during hPGCLC specification. BLIMP1 represses somatic
genes, including mesendodermal genes, which might allow
SOX17 to function as the regulator of hPGCLCs specification.
A mutation in BLIMP1 abrogates hPGCLC specification but
without completely abolishing SOX17 expression. However,
TNAP-positive cells were detected, in which PGC-specific genes
were repressed but some endodermal and other somatic genes
were upregulated. This suggests that BLIMP1 might repress
them during hPGCLC specification, but not excluding its wider
role in hPGCLC specification in conjunction with SOX17. In
mice, BLIMP1 also represses somatic genes in PGCs (Ohinata
et al., 2005; Vincent et al., 2005), but it is also a key determinant
of PGC specification, together with PRDM14 and TFAP2C
(Magnu´sdo´ttir et al., 2013).
Although PRDM14 is critical for mouse PGC specification, its
expression during hPGCLC specification is delayed and signifi-
cantly diminished in hPGCs and is very low in TCam-2 compared
to hESCs. PRDM14 is crucial for maintaining pluripotency in hu-
man and mouse ESCs, although different signaling moleculesFigure 7. Induction and Isolation of hPGCLCs from Competent hiPSCs
(A) FACS analysis of TNAP and NANOS3-mCherry (top) and TNAP and CD38 (bott
without preinduction (middle) or from conventional hESCs (right, Conv hESC).
(B) FACS analysis of TNAP and CD38 in 4i hiPSCs (top) and day 4 embryoids de
(C) Expression analysis by RT-qPCR on TNAP-positive hiPSCs (iPSC TNAP+)
double-positive population (TNAP+CD38+) on day 4 after hPGCLC induction. Re
indicate mean ± SD from two independent biological replicates.
(D) Overview of human germline development. hESCs in 4i reversibly attains com
results in strong induction of hPGCLCs following expression of SOX17-BLIMP1,
detected in in vivo gonadal hPGC and TCam-2 seminoma, indicating a likely prog
shared by all cells with germ cell characteristics, but not by hESC. Loss of SOX1regulate its expression, and the genomic targets in ESCs also
differ in the two species (Chia et al., 2010; Grabole et al., 2013;
Ma et al., 2011; Yamaji et al., 2013). The rapid downregulation
and delayed re-expression of PRDM14 at the onset of hPGCLC
induction (Figures 2F and S4A) may allow exit of pluripotency
from 4i hESC en route to germ cell differentiation. Interestingly,
the human and mouse PRDM14 proteins have diverged, which
might result in functional differences. There is expression of
SOX2 in mouse PGCs, which is apparently regulated by
PRDM14 (Grabole et al., 2013), whereas SOX2 is repressed in
human hPGCLCs/hPGCs. BLIMP1 also apparently represses
SOX2 during spontaneous differentiation of hPGCLCs from
hESCs (Lin et al., 2014). By contrast, KLF4 is expressed in
hPGCLCs /hPGCs (Figure 2C), but not in mouse PGCs (Kurimoto
et al., 2008). The precise significance of the repression and
expression of pluripotency genes, including NANOG, remains
to be elucidated.
Germ cell neoplasia or carcinoma in situ (CIS) (Skakkebaek,
1972) can generate embryonal carcinoma cells that resemble
hESCs or seminomas such as TCam-2 that inherit key character-
istics of germ cells (Looijenga et al., 2014; Schafer et al., 2011).
TCam-2 expresses SOX17, BLIMP1, TFAP2C, KIT, and DND1
with low levels of SOX2 and PRDM14. Knockdown of SOX17
in TCam-2 induces repression of germ cell and pluripotency
genes (Figure S6A), whereas knockdown of BLIMP1 and
TFAP2C induced upregulation of somatic genes (Weber et al.,
2010). These observations suggest that SOX17 and BLIMP1
might also be important for the maintenance of the early human
germline. We found that CD38 is a marker of all human germline-
related cells, including seminomas. Distinction between semi-
noma and embryonal carcinoma could therefore be made by
the expression of SOX17/CD38 and SOX2/CD30, respectively
(de Jong et al., 2008). Furthermore, CD38/TNAP are reliable
markers for the isolation of hPGCLCs derived from hESC/hiPSC
without any reporters.
The hPGCLCs also showed early signs of DNA demethylation,
which is consistent with the germline-specific epigenetic pro-
gram. The striking upregulation of 5hmC concomitantly with
TET1 suggests that, similar to mouse, conversion of 5mC to
5hmC may contribute to DNA demethylation in hPGC (Hackett
et al., 2013). Furthermore, repression of UHRF1 and DNMT3A
in hPGCLCs would promote DNA-replication-coupled loss of
5mC. Indeed, there was a small but significant decline in 5mC
in hPGCLCs, a trend that could lead to a significant loss of
5mC with further proliferation of hPGCLCs. Furthermore, we
detected upregulation and translocation of PRMT5 to the nu-
cleus in hPGCLC, which occurs with the onset of global DNA/hESCs
om) on day 4 embryoids induced from 4i hESCs after preinduction (left), directly
rived from 4i hiPSCs after direct induction (bottom).
, TNAP/CD38 double-negative (TNAPCD38) population and TNAP/CD38
lative expression levels are shown with normalization to bACTIN. Error bars
petence for germ cell fate. Exposure of 4i cells to cytokines containing BMPs
which are among the key regulators of germ cell fate. SOX17 and BLIMP1 are
ression of early human germ cell lineage. CD38, a cell-surface glycoprotein, is
7 or BLIMP1 abrogates hPGCLC specification.
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demethylation to repress transposable elements (Kim et al.,
2014). Detailed analysis of the transcriptome and epigenome,
together with the targets of SOX17 in hPGCLCs/hPGCs, should
provide insights on the mechanism of how the epigenome is
reset in the early human germline and potentially on the inheri-
tance and consequences of transgenerational epigenetic inher-
itance (Heard and Martienssen, 2014).
This study shows that changes in pluripotent cell states can be
induced by environmental factors with respect to gain and loss of
competence for germ cell fate in hESCs in the 4i culture (Gafni
et al., 2013). This competence for hPGCLCs is reversibly main-
tained and progressively lost in conventional culture conditions.
Notably, hESCs in 4i medium show a slight upregulation of T
together with HAND1 compared to conventional hESCs (Fig-
ure S7), with putative posterior primitive streak-like feature
(Mendjan et al., 2014). This might explain why hESC in 4i are
highly competent for hPGCLC fate. Because MAPK inhibitors
may also alter the epigenetic state of pluripotent cells (Gafni
et al., 2013), the precise molecular basis for competence for
PGC fate remains to be elucidated in both mouse and human.
Nonetheless, hESC/hiPSC can reversibly gain competence for
hPGCLC specification in 4i medium, which provides a model
for advances in human germ cell biology.
Mouse is the primary model organism for early mammalian
development, pluripotency, and the regulation of cell fates. Post-
implantation rodent embryos develop as egg cylinders with an
overlying extraembryonic ectoderm, which is the source of
signals, including BMP4, whereas postimplantation epiblast em-
bryonic disc in humans is typical of many mammalian species
(Barrios et al., 2013; de Fellici, 2013; Irie et al., 2014). These dif-
ferences may affect the source, duration, and the nature of
signaling molecules that regulate competence for cell fates
in vivo. The evolutionary divergence in the pluripotent states in
mouse and human might also result in differences in the mecha-
nism of germline specification and, potentially, other cell fate de-
cisions. If so, mechanisms of early cell fate decisions in mice
cannot be safely or wholly extrapolated to specification events
during early human development.
EXPERIMENTAL PROCEDURES
hESC/iPSC Culture and hPGCLC Differentiation
4i hESCs (WIS2: 46XY; WIBR3: 46XX; LIS1, 46XY) and iPSCs (FX71.1; a fragile
X male patient-derived iPSC line, C1 female iPSC line) were grown in condi-
tions adapted and modified from previously described WIS-NHSM conditions
(Gafni et al., 2013). 4i cells were grown on irradiated mouse embryonic fibro-
blasts (MEFs) (GlobalStem) in knockout DMEM supplemented with 20%
knockout serum replacement (KSR), 2 mM L-glutamine, 0.1 mM nonessential
amino acids, 0.1 mM 2-mercaptoethanol (all GIBCO), 20 ng/ml human LIF
(Stem Cell Institute [SCI]), 8 ng/ml bFGF (SCI), 1 ng/ml TGF-b1 (Peprotech),
3 mM CHIR99021 (Miltenyi Biotec), 1 mM PD0325901 (Miltenyi Biotec), 5 mM
SB203580 (TOCRIS bioscience), and 5 mM SP600125 (TOCRIS bioscience).
Cells were passaged every 3 to 5 days using TrypLE Express (GIBCO).
10 mM of ROCK inhibitor (Y-27632, TOCRIS bioscience) was used for 24 hr
after the passage.
To preinduce, 4i hESCs were dissociated with TrypLE Express and filtered
with 50 mm cell filter (PERTEC), and 43 105 cells/ 12-well were plated on vitro-
nectin/gelatin-coated plates (Gafni et al., 2013) in N2B27 medium (Ying et al.,
2008) with 1% KSR, 10 ng/ml bFGF (SCI), 1 ng/ml TGF-b1 (Peprotech), or
20 ng/ml Activin A (SCI) and 10 mM ROCK inhibitor. Medium was changed
on day 1. After 2 days of preinduction, the cells are dissociated with TrypLE266 Cell 160, 253–268, January 15, 2015 ª2015 The Authorsand plated to ultra-low cell attachment U-bottom 96-well plates (Corning,
7007) at a density of 2,000–4,000 cells/well in 200 ml PGCLC medium. PGCLC
medium is composed of Glasgow’s MEM (GMEM, GIBCO), 15%KSR, 0.1 mM
nonessential amino acids, 0.1 mM 2-mercaptoethanol, 100 U/ml Penicillin-
0.1 mg/ml Streptomycin, 2 mM L-Glutamine, 1 mM Sodium pyruvate, and
the following cytokines: 500 ng/ml BMP4 (R&D Systems) or BMP2 (SCI),
1 mg/ml human LIF (SCI), 100 ng/ml SCF (R&D Systems), 50 ng/ml EGF
(R&D Systems), and 10 mM ROCK inhibitor.
Conventional hESCs/hiPSCs were maintained on irradiated MEFs
(GlobalStem) in DMEM/F12+GlutaMAX supplemented with 20% KSR, 0.1 mM
nonessential amino acids, 0.1 mM 2-mercaptoethanol (all GIBCO), and 10–
20 ng/ml of bFGF (SCI). Media were replaced every day. Cells were passaged
every 4 to 6 days using 1 mg/ml of Dispase (GIBCO), and 10 mMROCK inhibitor
(Y-27632, TOCRIS bioscience) was added for 24 hr after the passage.
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